Bio-Rad Laboratories, Inc.
BIO- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000012208
No open-market purchases or sales by Bio-Rad Laboratories, Inc. insiders were filed in the last 90 days; 400 institutions reported holding it in 13F filings for Q2 2026, worth $5.70B in total; no superinvestor holds it.
Other share classesBIO.B
13F holders, Q2 2021
Institutional positions in Bio-Rad Laboratories, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 509
- +20 vs. Q1 2021
- Shares held
- 19.4M
- −169.2K (−0.9%) vs. Q1 2021
- Total value
- $12.5B
- +$1.33B (+11.9%) vs. Q1 2021
- New holders
- 61
- 193 more added
- Sold out
- 41
- 172 more reduced
3 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 400 | $5.70B |
| Q1 2026 | 395 | $5.57B |
| Q4 2025 | 400 | $5.88B |
| Q3 2025 | 397 | $5.46B |
| Q2 2025 | 385 | $4.63B |
| Q1 2025 | 435 | $4.71B |
| Q4 2024 | 457 | $6.17B |
| Q3 2024 | 440 | $6.50B |
| Q2 2024 | 441 | $5.41B |
| Q1 2024 | 466 | $6.42B |
| Q4 2023 | 487 | $5.98B |
| Q3 2023 | 471 | $6.73B |
| Q2 2023 | 470 | $7.19B |
| Q1 2023 | 508 | $9.20B |
| Q4 2022 | 472 | $8.11B |
| Q3 2022 | 485 | $8.13B |
| Q2 2022 | 502 | $9.46B |
| Q1 2022 | 515 | $10.8B |
| Q4 2021 | 534 | $14.4B |
| Q3 2021 | 509 | $14.5B |
| Q2 2021 | 509 | $12.5B |
| Q1 2021 | 492 | $11.2B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Bio-Rad Laboratories, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westfield Capital Management Co LP | 406,272 | $261.8M | 1.57% | +1,805+0.4% | Added |
| Marshall Wace, LLP | 435,099 | $280.3M | 1.48% | −133,819−23.5% | Reduced |
| Alliancebernstein L.P. | 523,975 | $337.6M | 0.14% | +57,614+12.4% | Added |
| Brown Advisory Inc | 569,232 | $366.8M | 0.55% | +37,045+7.0% | Added |
| State Street Corp | 974,441 | $627.8M | 0.03% | +2,702+0.3% | Added |
| FMR LLC | 1,609,022 | $1.04B | 0.08% | +68,564+4.5% | Added |
| BlackRock Inc. | 1,839,067 | $1.18B | 0.03% | −71,816−3.8% | Reduced |
| Vanguard Group Inc | 2,281,698 | $1.47B | 0.04% | −6,440−0.3% | Reduced |
| Sofos Investments, Inc. | 1 | – | – | 00.0% | Unchanged |
| Tikvah Management LLC | 0 | $0 | 0.00% | −126,282−100.0% | Sold out |
| Clearbridge Investments, LLC | 0 | $0 | 0.00% | −104,668−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −11,743−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −8,765−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −8,637−100.0% | Sold out |
| Sivik Global Healthcare LLC | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −6,331−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −6,163−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −4,967−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,370−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −2,549−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −1,377−100.0% | Sold out |
| Capitolis Advisors LLC | 0 | $0 | 0.00% | −1,248−100.0% | Sold out |
| AGF Investments LLC | 0 | $0 | 0.00% | −1,184−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −968−100.0% | Sold out |
| BCJ Capital Management, LLC | 0 | $0 | 0.00% | −917−100.0% | Sold out |
| LS Investment Advisors, LLC | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −553−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −585−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −529−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −523−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Agf Investments Inc. | 0 | $0 | 0.00% | −372−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| Banco de Sabadell, S.A | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Stephenson National Bank & Trust | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Valley Brook Capital Group | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| RMR Wealth Builders | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Sun Life Financial INC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Logan Capital Management Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Grandview Asset Management LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |
| BBVA USA Bancshares, Inc. | – | – | – | – | Not filed |
| CSat Investment Advisory, L.P. | – | – | – | – | Not filed |